Clinical trial
Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000173 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00000173 |
|---|---|
| Title | Memory Impairment Study (Mild Cognitive Impairment Study) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin E and Donepezil HCL (Aricept) to Delay Clinical Progression From Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Donepezil, Vitamin E |
| Start date | Mar 1, 1999 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Nov 1, 1999 |
| Last update posted | Dec 11, 2009 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: